YOLFTbeta
Biocardia Inc

Biocardia Inc

BCDA · NASDAQ · Healthcare / Biotechnology

0.83USD+0.00 (+0.48%)

Price History

Full chart

Market Stats

Previous Close0.826
Open0.97
Day Range0.82 – 0.97
52-Week Range0.75 – 1.58
Volume79.20K
Market Cap16.20M
P/E (TTM)0.00
Forward P/E0.00
EPS-0.60
Dividend Yield0.00%
Beta0.55
50-Day Avg1.00
200-Day Avg1.12

About

BioCardia, Inc., a clinical-stage regenerative medicine company, develops cellular and cell-derived therapeutics for cardiovascular and pulmonary diseases in the United States. The company's lead product candidate is CardiAMP, an autologous mononuclear cell therapy system in Phase III clinical trial for the treatment of ischemic heart failure with reduced ejection fraction and refractory angina resulting from chronic myocardial ischemia. It also provides CardiALLO, an allogeneic mesenchymal stem cell therapy which is in phase II for ischemic heart failure; allogeneic cell therapy platform; and PulmALLO, an allogeneic mesenchymal stem cell therapy for acute respiratory distress syndrome. In addition, the company offers the Helix biotherapeutic delivery system for minimally invasive targeted delivery of biologic agents to the heart; Heart3D for fusion imaging; and morph DNA and avance steerable introducers. It has a license and distribution agreement with Biomet Biologics, LLC. BioCardia, Inc. is based in Sunnyvale, California.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEODr. Peter A. Altman Ph.D.
  • Employees17
  • Headquarters320 Soquel Way, Sunnyvale, CA, United States, 94085, USA
  • Websitehttps://www.biocardia.com

Leadership

  • Dr. Peter A. Altman Ph.D.CEO, President & Director · b. 1967
  • Mr. David McClungChief Financial Officer · b. 1963
  • Mr. Edward M. GillisSenior Vice President of Devices · b. 1962
  • Ms. Miranda Peto BenvenutiInvestor Relations Executive

Financials

Income Statement

Currency: USD1995-12-311996-12-311997-12-311998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue3.15M3.40M3.40M3.80M4.20M3.99M3.87M3.96M4.08M3.76M--643.00K1.27M1.87M-12.00K62.00K268.00K427.00K517.00K576.00K479.00K625.00K710.00K145.00K1.01M1.35M477.00K58.00K0
Growth (%)-+8.01%0.00%+11.76%+10.53%-5.05%-3.06%+2.35%+3.06%-7.82%---+97.20%+47.40%--+416.67%+332.26%+59.33%+21.08%+11.41%-16.84%+30.48%+13.60%-79.58%+600.00%+33.20%-64.72%-87.84%-100.00%
Cost of Revenue727.61K800.00K800.00K900.00K1.00M898.17K952.26K971.25K1.01M860.33K--130.00K197.00K380.00K---3.59M2.70M1.06M746.00K690.00K517.00K358.00K4.00K640.00K11.90M7.73M4.39M505.00K
Gross Profit2.42M2.60M2.60M2.90M3.20M3.09M2.91M2.99M3.07M2.90M--513.00K1.07M1.49M-12.00K62.00K268.00K427.00K517.00K-170.00K-211.00K108.00K352.00K141.00K375.00K-10.55M-7.25M-4.33M-505.00K
Gross Margin76.87%76.47%76.47%76.32%76.19%77.48%75.38%75.46%75.33%77.12%--79.78%84.46%79.67%-100.00%100.00%100.00%100.00%100.00%-29.51%-44.05%17.28%49.58%97.24%36.95%-780.25%-1519.71%-7463.79%-
Operating Expense2.21M3.30M3.30M4.00M4.40M5.02M4.93M4.14M3.58M3.68M--592.80K6.70M6.59M-630.00K401.00K259.00K196.00K198.00K7.44M12.19M14.21M14.56M15.67M13.01M1.35M4.39M3.67M7.77M
Operating Income206.23K-700.00K-700.00K-1.10M-1.20M-1.93M-2.02M-1.15M-504.00K-780.00K-101.48K-92.80K-79.80K-5.63M-5.10M-583.00K-618.00K-339.00K9.00K231.00K319.00K-7.61M-12.40M-14.10M-14.21M-15.53M-12.63M-11.90M-11.64M-8.00M-8.28M
Operating Margin6.55%-20.59%-20.59%-28.95%-28.57%-48.29%-52.20%-29.14%-12.36%-20.75%---12.41%-444.16%-272.98%--5150.00%-546.77%3.36%54.10%61.70%-1320.83%-2589.77%-2256.32%-2001.83%-10709.66%-1244.33%-880.25%-2441.09%-13794.83%-
EBITDA-600.00K-500.00K-1.00M-1.00M-1.10M-1.81M-1.91M-1.05M-419.00K-263.00K-101.48K-92.80K-79.80K-3.61M-3.90M384.00K-618.00K-339.00K9.00K231.00K319.00K-8.54M-12.23M-13.90M-14.05M-14.44M-12.57M-11.82M-11.49M-7.88M-7.72M
EBITDA Margin-19.06%-14.71%-29.41%-26.32%-26.19%-45.39%-49.41%-26.56%-10.27%-7.00%---12.41%-285.02%-208.40%--5150.00%-546.77%3.36%54.10%61.70%-1481.77%-2553.24%-2223.84%-1978.31%-9955.17%-1238.42%-874.19%-2408.18%-13584.48%-
Net Income135.60K-600.00K-600.00K-600.00K-1.30M-1.54M-2.18M-1.23M-480.00K-723.00K-812.34K-92.80K-75.44K-5.80M-5.08M-11.51M9.66M305.00K19.00K234.00K322.00K-10.31M-12.31M-13.99M-14.71M-15.00M-12.62M-11.91M-11.57M-7.95M-8.23M
Net Income Margin4.31%-17.65%-17.65%-15.79%-30.95%-38.72%-56.36%-31.01%-11.77%-19.23%---11.73%-457.41%-271.70%-80516.67%491.94%7.09%54.80%62.28%-1789.93%-2569.52%-2237.92%-2071.69%-10347.59%-1243.45%-881.14%-2425.79%-13700.00%-
R&D------------215.00K1.33M1.00M---2.22M1.52M1.52M3.33M5.80M8.45M8.56M9.81M8.56M8.83M7.73M4.39M4.96M
R&D as % of Total Revenue------------33.44%105.05%53.67%---827.99%355.50%293.62%578.13%1210.65%1352.48%1205.92%6764.83%843.15%653.40%1619.71%7563.79%-
Interest Expense32.00K00000000000048.00K24.00K27.00K25.00K8.00K10.00K3.00K3.00K1.74M95.00K118.00K112.00K3.00K9.00K6.00K---
Interest Expense % of Total Revenue1.02%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%--0.00%3.79%1.28%-208.33%12.90%3.73%0.70%0.58%301.39%19.83%18.88%15.77%2.07%0.89%0.44%---

Balance Sheet

Currency: USD1995-12-311996-12-311997-12-311998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets938.99K4.70M4.70M4.10M3.20M7.43M4.19M2.96M2.64M1.71M897.27K174.92K87.11K11.47M15.59M5.43M13.73M13.30M13.33M13.54M13.88M22.08M13.54M6.42M7.68M23.42M15.72M9.79M2.99M3.72M3.41M
Total Liabilities1.01M600.00K600.00K700.00K1.00M1.16M782.74K868.49K963.32K742.45K720.54K33.37K25.83K777.00K851.00K2.16M756.00K12.00K18.00K1.00K10.00K1.50M2.41M2.63M5.31M4.25M5.34M4.90M4.59M2.89M2.52M
Total Equity-71.75K4.10M4.10M3.40M2.20M6.27M3.40M2.09M1.68M963.58K176.73K141.55K61.28K10.70M14.74M3.28M12.98M13.29M13.31M13.54M13.87M20.58M11.13M3.79M2.37M19.18M10.38M4.89M-1.60M837.00K895.00K
Cash31.47K200.00K200.00K1.40M1.80M5.98M2.56M1.92M1.80M730.87K870.68K153.12K82.10K3.10M4.97M127.00K12.68M13.27M13.29M13.51M13.84M21.35M12.69M5.36M5.58M21.41M12.87M7.36M1.10M2.37M2.50M
Total Debt---------------500.00K---7.50M5.67M---1.14M614.00K1.87M1.63M1.31M951.00K528.00K
Net Debt-31.47K-200.00K-200.00K-1.40M-1.80M-5.98M-2.56M-1.92M-1.80M-730.87K-870.68K-153.12K-82.10K-3.10M-4.97M373.00K-12.68M-13.27M-13.29M-6.01M-8.17M-21.35M-12.69M-5.36M-4.44M-20.79M-11.00M-5.73M212.00K-1.42M-1.97M

Cash Flow

Currency: USD1995-12-311996-12-311997-12-311998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow263.39K-500.00K-500.00K-700.00K-1.00M-1.38M-1.53M-491.22K-297.66K-749.42K-455.82K-741.46K-47.12K-2.70M-4.78M-4.28M-3.09M-310.00K27.00K214.00K331.00K-5.52M-8.67M-11.07M-9.45M-12.36M-10.37M-10.56M-9.97M-8.03M-7.44M
Investing Cash Flow-127.95K--3.70M1.90M1.30M-64.48K-172.21K-78.92K179.38K-318.50K531.47K---1.84M-2.35M-1.07M16.14M900.00K-27.00K-53.00K-125.00K18.92M-136.00K-66.00K-146.00K-32.00K-116.00K-70.00K-12.00K-6.00K-7.00K
Financing Cash Flow-160.04K4.40M4.40M-5.65M5.65M-1.71M-71.16K-64.16K64.16K-2.85M6.72M9.01M500.00K-500.00K-5.07M7.81M7.57M4.40M144.00K3.80M9.82M28.21M1.95M5.12M3.73M9.30M7.57M
Capital Expenditure124.53K0100.00K100.00K133.38K133.38K126.91K9.52K11.82K12.83K000515.00K1.02M1.07M137.00K027.00K53.00K125.00K136.00K136.00K66.00K146.00K32.00K116.00K70.00K12.00K6.00K7.00K
Free Cash Flow138.85K-500.00K-500.00K-800.00K-1.00M-1.52M-1.66M-500.74K-309.48K-762.24K-455.82K-741.46K-47.12K-3.21M-5.80M-5.35M-3.22M-310.00K27.00K161.00K206.00K-5.52M-8.81M-11.13M-9.59M-12.39M-10.48M-10.63M-9.99M-8.03M-7.44M
Dividends Paid124.00K------------6.20M-----------346.00K-----
FCF to OCF52.72%100.00%100.00%114.29%100.00%109.63%108.29%101.94%103.97%101.71%100.00%100.00%100.00%119.10%121.28%124.99%104.44%100.00%100.00%75.23%62.24%100.00%101.57%100.60%101.55%100.26%101.12%100.66%100.12%100.07%100.09%
Dividend Paid to FCF89.30%-------------193.12%------------2.79%-----

Earnings

Report DateMar 31, 1999Dec 31, 1999Mar 31, 2000Sep 30, 2000Dec 31, 2000Mar 31, 2001Sep 30, 2001Dec 31, 2001Mar 31, 2002Sep 30, 2002Dec 31, 2002Mar 31, 2003Aug 15, 2003Nov 15, 2003Feb 13, 2004May 15, 2004Sep 28, 2004Nov 15, 2004Mar 2, 2005Jun 1, 2005Nov 30, 2005Mar 1, 2006May 31, 2006Sep 27, 2006Nov 9, 2006Feb 8, 2007May 14, 2007Sep 21, 2007Dec 3, 2008Feb 25, 2009May 18, 2009Aug 17, 2009Nov 13, 2009Mar 3, 2010May 14, 2010Aug 12, 2010Nov 22, 2010Mar 31, 2011May 16, 2011Aug 11, 2011Nov 15, 2011Mar 29, 2012May 11, 2012Aug 10, 2012Nov 16, 2012Mar 22, 2013May 13, 2013Aug 16, 2013Nov 15, 2013Mar 21, 2014May 12, 2014Aug 15, 2014Nov 14, 2014Mar 20, 2015May 11, 2015Aug 14, 2015Nov 13, 2015Mar 18, 2016May 9, 2016Aug 12, 2016Nov 11, 2016May 15, 2017Aug 11, 2017Nov 9, 2017Mar 16, 2018May 10, 2018Aug 9, 2018Nov 8, 2018Mar 22, 2019May 15, 2019Aug 14, 2019Nov 19, 2019Dec 31, 2019Apr 9, 2020Aug 13, 2020Nov 10, 2020Mar 30, 2021May 13, 2021Aug 12, 2021Nov 10, 2021Mar 29, 2022May 11, 2022Aug 10, 2022Nov 9, 2022Mar 29, 2023May 10, 2023Aug 9, 2023Nov 8, 2023Mar 27, 2024May 14, 2024Aug 13, 2024Nov 13, 2024Mar 25, 2025May 14, 2025Aug 11, 2025Nov 12, 2025Mar 24, 2026May 15, 2026Aug 12, 2026Nov 11, 2026
EPS Estimate------------------------------------------------------------------------8.70-0.51-8.40-6.00-4.35-4.65-0.24-3.45-4.20-0.21-2.40-6.30-3.15-0.18-1.95-2.55-1.65-1.50-0.20-0.10-1.19-0.87-0.39-0.50-0.25-0.20-0.17-0.19-0.15
EPS Actual-385.62-215.35-895.43-1068.15-1924.46-1031.30-890.16-518.27-551.62-401.37-219.29-408.4565.83-127.43-5.10-32.40-21.60-21.60-113.31-935.44-64.37-33.81-37.01-9.73-2.73-17.41-15.02-16.88-10.21-21.87-9.75-10.67-9.47-10.23-6.14-6.26-3.80-1.94-1.3545.74-0.26-1.19-0.39-0.913.170.27-0.180.060.210.040.450.460.300.430.530.510.580.630.580.5335.99-10.18-10.42-0.72-0.81-7.59-0.72-0.81-0.85-0.85-0.77-9.45-0.48-7.20-6.90-4.50-3.05-0.18-3.00-2.40-0.20-2.85-2.10-2.55-0.16-2.55-2.55-1.80-1.35-0.09-0.88-0.61-0.25-0.59-0.40-0.24-0.06-0.21-0.13-
Surprise------------------------------------------------------------------------8.62%5.88%14.29%-15.00%-3.45%34.41%25.00%13.04%42.86%4.76%-18.75%66.67%19.05%11.11%-30.77%0.00%-9.09%10.00%54.90%-780.00%48.74%71.26%-51.28%20.00%4.00%70.00%-23.53%31.58%-
Timing------------After-hoursAfter-hoursAfter-hours-After-hoursAfter-hours-----After-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hours------After-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hours---------------------After-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hours-After-hoursAfter-hoursAfter-hours-After-hoursPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursPre-marketAfter-hoursAfter-hours-After-hours-

Key Statistics & Ratios

Market Cap16.20M
Enterprise Value12.07M
Trailing P/E0.00
Forward P/E0.00
PEG Ratio0.00
Price / Sales2520.59
Price / Book5.89
EPS-0.60
Book Value0.18
Revenue (TTM)0
Gross Profit (TTM)-4.19M
EBITDA-7.38M
Profit Margin0.00%
Operating Margin0.00%
Return on Equity-1803.19%
Return on Assets-134.97%
Shares Outstanding15.14M
Shares Float12.26M
Beta0.55
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Analyst Ratings

Strong Buy
Based on 1 analystsTarget 15.50
  • Strong Buy
    1

Ownership Breakdown

Institutions
14.79%
Insiders
17.91%
Retail / Other
67.30%

Top Institutional Holders

  • CM Management, LLC
    130.00K0.86%
  • Vanguard Capital Management, LLC
    124.59K0.82%
  • Geode Capital Management, LLC
    94.29K0.62%
  • Vanguard Fiduciary Trust Co
    66.27K0.44%
  • Susquehanna International Group, LLP
    38.83K0.26%
  • Pingora Partners LLC
    35.74K0.24%
  • Brown Advisory Holdings Inc
    35.54K0.23%
  • XTX Topco Ltd
    24.27K0.16%
  • Commonwealth Equity Services, LLC
    23.38K0.15%
  • Citadel Advisors Llc
    22.96K0.15%
  • Virtu Financial LLC
    20.36K0.13%
  • TWO SIGMA SECURITIES, LLC
    14.78K0.10%
  • Renaissance Technologies Corp
    13.90K0.09%
  • GSA Capital Partners LLP
    12.86K0.09%
  • Morgan Stanley - Brokerage Accounts
    3.10K0.02%

Top Fund Holders

  • Vanguard MStar Total Stk Mkt Idx Invest
    55.57K0.37%
  • Fidelity Extended Market Index
    46.48K0.31%
  • Abante Quant Value FI
    38.88K0.26%
  • Fidelity Series Total Market Index
    10.53K0.07%
  • Fidelity Total Market Index
    3.24K0.02%

Stock Splits

  • May 30, 20241:15
  • Jun 6, 20191:9
  • Nov 3, 20171:12
  • Mar 14, 20081:10
  • Jan 6, 20046:1
  • Aug 23, 20011:3